- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
46
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
46 companies
Sotera Health
Market Cap: US$3.0b
Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$10.49
7D
-7.3%
1Y
-2.4%
BioLife Solutions
Market Cap: US$1.1b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$22.26
7D
-2.3%
1Y
47.0%
Hunan Jiudian Pharmaceutical
Market Cap: CN¥8.3b
Researches, develops, produces, and sells pharmaceutical products in China and internationally.
300705
CN¥16.69
7D
0.8%
1Y
-33.1%
Medical Developments International
Market Cap: AU$52.4m
Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.
MVP
AU$0.47
7D
2.2%
1Y
-15.5%
Xiamen Amoytop Biotech
Market Cap: CN¥31.5b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥77.45
7D
4.6%
1Y
18.5%
ALTEOGEN
Market Cap: ₩19.5t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩366,500.00
7D
5.5%
1Y
127.9%
Senores Pharmaceuticals
Market Cap: ₹25.5b
Develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally.
SENORES
₹553.15
7D
7.3%
1Y
n/a
Genscript Biotech
Market Cap: HK$22.6b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$10.46
7D
5.4%
1Y
-9.0%
Genetic Signatures
Market Cap: AU$105.6m
Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.
GSS
AU$0.47
7D
16.3%
1Y
-33.6%
Formycon
Market Cap: €416.7m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€23.35
7D
14.5%
1Y
-41.9%
Zhejiang Wolwo Bio-Pharmaceutical
Market Cap: CN¥10.4b
A biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally.
300357
CN¥19.90
7D
-1.5%
1Y
-11.9%
Zhejiang Tianyu Pharmaceutical
Market Cap: CN¥6.5b
Engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally.
300702
CN¥18.97
7D
7.1%
1Y
12.4%
Almirall
Market Cap: €2.0b
Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.
ALM
€9.39
7D
7.2%
1Y
15.9%
SK Biopharmaceuticals
Market Cap: ₩8.0t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩102,600.00
7D
7.5%
1Y
27.1%
Betta Pharmaceuticals
Market Cap: CN¥21.6b
Researches and develops, manufactures, and markets medicines for the treatment of cancer in China.
300558
CN¥51.62
7D
5.7%
1Y
39.7%
Vertex Pharmaceuticals
Market Cap: US$128.5b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTX
US$485.89
7D
0.7%
1Y
23.6%
Solara Active Pharma Sciences
Market Cap: ₹25.0b
Manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally.
SOLARA
₹519.25
7D
6.2%
1Y
22.7%
Eli Lilly
Market Cap: US$677.4b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$757.18
7D
4.3%
1Y
1.4%
Repligen
Market Cap: US$7.1b
A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
RGEN
US$132.26
7D
6.8%
1Y
-17.8%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €171.4m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€6.90
7D
-0.6%
1Y
-17.5%
Seegene
Market Cap: ₩1.1t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩24,250.00
7D
7.8%
1Y
15.5%
Bruker
Market Cap: US$5.8b
Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
BRKR
US$37.74
7D
-8.4%
1Y
-54.5%
ArcticZymes Technologies
Market Cap: NOK 868.2m
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, rest of Europe, the United States, and internationally.
AZT
NOK 17.00
7D
13.3%
1Y
-36.0%
Suzhou Zelgen BiopharmaceuticalsLtd
Market Cap: CN¥26.9b
Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
688266
CN¥101.80
7D
6.7%
1Y
113.1%
Akeso
Market Cap: HK$75.1b
A biopharmaceutical company, researches, develops, manufactures, and commercializes antibody drugs.
9926
HK$83.70
7D
17.6%
1Y
79.0%
Walvax Biotechnology
Market Cap: CN¥16.7b
Researches, develops, produces, and markets vaccines in China.
300142
CN¥10.43
7D
-1.6%
1Y
-26.6%
Bonesupport Holding
Market Cap: SEK 21.0b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 317.20
7D
9.9%
1Y
33.2%
Recordati Industria Chimica e Farmaceutica
Market Cap: €10.0b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€48.50
7D
8.3%
1Y
-0.9%
SKAN Group
Market Cap: CHF 1.4b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 62.30
7D
4.9%
1Y
-23.3%
RemeGen
Market Cap: HK$23.6b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$34.90
7D
35.8%
1Y
28.8%
CSPC Innovation Pharmaceutical
Market Cap: CN¥58.5b
Engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally.
300765
CN¥42.00
7D
9.7%
1Y
36.3%
AddLife
Market Cap: SEK 18.8b
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 155.40
7D
12.4%
1Y
58.7%
Telix Pharmaceuticals
Market Cap: AU$8.7b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States.
TLX
AU$25.87
7D
5.9%
1Y
106.3%
CellSource
Market Cap: JP¥12.3b
Engages in the regenerative medicine-related businesses in Japan.
4880
JP¥619.00
7D
5.8%
1Y
-57.4%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$65.7b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs to address unmet medical needs in the People’s Republic of China and internationally.
6990
HK$289.00
7D
8.8%
1Y
107.2%
Saudi Pharmaceutical Industries and Medical Appliances
Market Cap: ر.س2.9b
Develops, manufactures, and markets of medicinal and pharmaceutical products in the Kingdom of Saudi Arabia, the Middles East, Egypt, and Morocco.
2070
ر.س24.70
7D
8.3%
1Y
-31.3%